610O Preliminary results from a phase I, first-in-human study of DS-9606a, a claudin 6 (CLDN6)-directed antibody-drug conjugate (ADC), in patients (pts) with tumor types known to express CLDN6 - Concepedia

Concepedia

Publication | Open Access

610O Preliminary results from a phase I, first-in-human study of DS-9606a, a claudin 6 (CLDN6)-directed antibody-drug conjugate (ADC), in patients (pts) with tumor types known to express CLDN6

DOI Full Paper Access

11

Citations

0

References

2024

Year

Manish Patel, E.P. Hamilton, Sarina A. Piha‐Paul, J. Henry, Udai Banerji, Mohammed Najeeb Al Hallak, Hitoshi Okada, M. Qian, X. Zhang, Nur Akmarina B.M. Said,

Annals of Oncology

No additional data available for this publication yet. Check back later!